Media is biomanufacturing’s untapped advantage.
More medicines, materials, and foods are now made using cells than ever before, making the culture media that support their growth essential to production. At the same time, patent expiries, regulatory reform, and efforts to bring supply chains closer to home are pushing manufacturers to reliably make more for less. Media design offers opportunities to address these challenges.
Yet media development has struggled to keep pace, partly because developing it is intrinsically hard. A full formulation can contain 100+ interacting ingredients, and even just three concentrations for each creates more possible combinations than there are grains of sand on Earth. Conventional labs can test only a tiny fraction of these, so most media remain under-optimised. Resolving these pressures requires a different approach to media development.
Three pressures are converging. Custom media design can help to address all three.
of US sales from biologics lose exclusivity by 2034, about twelve biologics a year1
of FDA rejections since 2020 trace to inadequate media2
Critical manufacturing is moving closer to home, increasing the importance of reliable, scalable supplies of media ingredients
Media development hasn’t kept pace.
of biomedical research still runs on formulations designed in the 1950s and 1960s3
interacting ingredients in a full formulation
possible formulations from 100 ingredients at just three concentrations each – too many to search by trial and error
- 1. IQVIA Institute (2025)
- 2. Pazhayattil et al., ISPE (2024)
- 3. Cox et al. (2020)
Media is a data problem.
MediOP™ is built to solve it.
Finding the right formulation means testing far more combinations than any lab can run manually, leaving traditional media development to chance. Our MediOP™ platform combines high-throughput robotic automation, AI, and deep cell biology expertise into an iterative process of formulation design, testing, and learning. We generate rich performance data at scale, and use it to guide successive rounds of experiments, refining media formulations around your cells and processes.
Inside MediOP™- 01
Design
Formulations tailored to the specific needs of each cell line, rather than simply adapting off-the-shelf recipes.
100+ interacting ingredients per formulation - 02
Test
Robotics prepare unique formulations in parallel, and plates cycle through incubations on schedule.
AI readout03Read
Every well imaged and segmented. MediOP™ interprets what the cells require.
- >50Mdata points+~200k every cycle04
Learn
Results train the model and are fed into experimental design. Every run makes the next one faster.
>50M data points generated by MediOP™
Better media means better biomanufacturing.
Enhanced media help to unlock the next wave of innovations across therapeutics, food, and advanced materials. We’re partnering with industry leaders to accelerate biomanufacturing breakthroughs and unlock their cells’ potential.